Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

501
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
501
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Overall Survival in Patients With Multiple Primary Lung Cancer: Nomogram Development and Validation Study.

JMIR cancer·2026
Same author

Association of serum parathyroid hormone within normal range with the prevalence and prognosis among adults with diabetes and prediabetes: insight from NHANES 2003-2006 data.

Therapeutic advances in endocrinology and metabolism·2025
Same author

The Mechanisms of Resistin-Like Molecule-β-Mediated Airway Inflammation in Chronic Obstructive Pulmonary Disease via Autophagy.

Journal of inflammation research·2023
Same author

Construction and evaluation of a risk prediction model for pulmonary infection-associated acute kidney injury in intensive care units.

Clinical and translational science·2023
Same author

Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma.

Allergy, asthma & immunology research·2022
Same author

Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.

Computational and mathematical methods in medicine·2022

Related Experiment Video

Updated: Sep 6, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K

Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients.

Li Che1, Guangshu Chen2, Xingdong Cai1

  • 1Department of Pulmonary and Critical Care Medicine, Jinan University First Affiliated Hospital, Guangzhou 510630, China.

Biomed Research International
|June 24, 2022
PubMed
Summary
This summary is machine-generated.

This study identifies 34 common differentially expressed genes between Chronic Obstructive Pulmonary Disease (COPD) and COVID-19. Artesunate, dexverapamil, and STOCK1N-35696 show potential as therapeutic agents for both conditions.

More Related Videos

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 6, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K
Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
09:26

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

1.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Area of Science:

  • Genomics
  • Bioinformatics
  • Pharmacology

Background:

  • COVID-19 remains a global health threat, particularly for individuals with Chronic Obstructive Pulmonary Disease (COPD).
  • COPD patient susceptibility to COVID-19 is linked to the ACE2 receptor targeted by SARS-CoV-2.
  • Understanding shared genetic underpinnings is crucial for effective treatment strategies.

Purpose of the Study:

  • To identify common differentially expressed genes (DEGs) between COVID-19 and COPD.
  • To explore enriched signaling pathways and key hub genes.
  • To discover potential therapeutic agents targeting shared molecular mechanisms.

Main Methods:

  • Utilized bioinformatics approaches to analyze transcriptomic gene expression data from the GEO database for both diseases.
  • Performed pathway enrichment analysis and constructed a protein-protein interaction (PPI) network for common DEGs.
  • Identified hub genes and analyzed regulatory networks involving transcription factors and microRNAs.

Main Results:

  • Identified 34 common DEGs between COVID-19 and COPD datasets.
  • Enriched signaling pathways involved intercellular junctions and cytokine regulation.
  • Extracted 5 hub genes from the PPI network, highlighting potential therapeutic targets.

Conclusions:

  • Artesunate, dexverapamil, and STOCK1N-35696 emerged as potential therapeutic candidates for co-occurring COPD and COVID-19.
  • These agents may target shared pathways identified through DEG analysis.
  • Further research is warranted to validate these findings in clinical settings.